Epidemiology of hepatocellular carcinoma
- PMID: 15831268
- DOI: 10.1016/j.cld.2004.12.009
Epidemiology of hepatocellular carcinoma
Abstract
Year 2000 estimates of the incidence of cancer indicate that primary liver cancer remains the fifth most common malignancy in men and the eighth in women. The number of new cases has been predicted as 564,000, corresponding to 398,000 in men and 166,000 in women. The geographic areas at highest risk are located in Eastern Asia, Middle Africa, and some countries of Western Africa. Changes in incidence among migrant populations underline the predominant role of environmental factors in the etiology of primary liver cancer. In high-risk countries, the early cases of primary liver cancer occur already at ages 20 and above, underlying the impact of viral exposures early in life. In countries at low risk, primary liver cancer is rare before the 50s, translating the impact of late exposures with moderate risks and long latency intervals. Sex ratios are typically between 2 and 4. The incidence of primary liver cancer is increasing in several developed countries including the United States, and the increase will likely continue for several decades. The trend has a dominant cohort effect related to exposures to hepatitis B and C viruses. The variability of primary liver cancer incidence is largely explained by the distribution and the natural history of the hepatitis B and C viruses. The attributable risk estimates for the combined effects of these infections account for well over 80% of liver cancer cases worldwide. Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses.
Similar articles
-
Epidemiology of primary liver cancer.Semin Liver Dis. 1999;19(3):271-85. doi: 10.1055/s-2007-1007117. Semin Liver Dis. 1999. PMID: 10518307 Review.
-
Hepatocellular cancer: a guide for the internist.Am J Med. 2007 Mar;120(3):194-202. doi: 10.1016/j.amjmed.2006.11.020. Am J Med. 2007. PMID: 17349437 Review.
-
Epidemiology and natural history of hepatocellular carcinoma.Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):3-23. doi: 10.1016/j.bpg.2004.10.004. Best Pract Res Clin Gastroenterol. 2005. PMID: 15757802 Review.
-
Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.Oncogene. 2006 Jun 26;25(27):3771-7. doi: 10.1038/sj.onc.1209560. Oncogene. 2006. PMID: 16799618 Review.
-
[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].Zentralbl Chir. 2007 Aug;132(4):300-5. doi: 10.1055/s-2007-981195. Zentralbl Chir. 2007. PMID: 17724632 Review. German.
Cited by
-
Risk profile of hepatocellular carcinoma reveals dichotomy among US veterans.J Gastrointest Cancer. 2013 Sep;44(3):318-24. doi: 10.1007/s12029-013-9499-1. J Gastrointest Cancer. 2013. PMID: 23609167 Clinical Trial.
-
Role of ERCC5 polymorphism in risk of hepatocellular carcinoma.Oncol Lett. 2011 Sep 1;2(5):911-914. doi: 10.3892/ol.2011.325. Epub 2011 Jun 10. Oncol Lett. 2011. PMID: 22866149 Free PMC article.
-
Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinoma.Clin Epigenetics. 2016 Apr 22;8:41. doi: 10.1186/s13148-016-0208-3. eCollection 2016. Clin Epigenetics. 2016. PMID: 27110298 Free PMC article.
-
Decreased aquaporin expression leads to increased resistance to apoptosis in hepatocellular carcinoma.Cancer Lett. 2007 May 18;250(1):36-46. doi: 10.1016/j.canlet.2006.09.013. Epub 2006 Nov 3. Cancer Lett. 2007. PMID: 17084522 Free PMC article.
-
Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis.J Gastrointest Surg. 2008 Jan;12(1):192-8. doi: 10.1007/s11605-007-0392-8. Epub 2007 Nov 13. J Gastrointest Surg. 2008. PMID: 17999123
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical